The Powell Perspective

Private equity firm Argosy Healthcare Partners invests in Command Medical Products, bringing in a new CEO as the medical device contract manufacturing market surges. A look at the company's strategy and industry trends.

Industry leader Kevin E. Lawler takes the helm at Michael Baker, promising innovation, client focus, and a deepened commitment to sustainable infrastructure solutions. A look at what this leadership shift means for the firm’s future.

With the local video ad market set for double-digit growth, Locality has appointed a new CEO to bridge the gap between traditional TV and rapidly expanding streaming, positioning the company for a leading role in a transforming landscape.

A surge in DoD spending on AI & unmanned systems is bolstering M-tron Industries, a key component supplier poised for growth as defense contractors ramp up production. A deep dive into the company’s strategy & future outlook.

Lightspeed Commerce taps ex-Medallia & Contentsquare executive Gabriel Benavides as its new CRO, signaling a sharpened focus on streamlining operations and accelerating growth in key markets.

A veteran real estate firm is doubling down on social impact with the launch of LegacyFirst, a new company dedicated to transforming underutilized properties into engines of economic prosperity. The move signals a growing trend in mission-driven investment.

Canadian firm 3iQ aims to capitalize on growing institutional interest in digital assets within Switzerland, Germany, and Austria, appointing Christophe Racine to lead the expansion.

Broadridge appoints Richard Street to drive international growth, leveraging his fintech experience and strategic acquisitions to expand its reach in key global markets.

Dubai Chamber of Commerce launches a New York office as part of a broader strategy to attract US investment, particularly in AI, cybersecurity, and digital transformation. A closer look at the emirate's growing economic ambitions.

A new report reveals a widening gap between employee expectations for ethical leadership and the actual behavior of CEOs. The HOW Institute aims to bridge that gap with a unique fellowship program and a focus on ‘how’ leaders achieve results.

Fortune Media boosts European presence with top hires Kamal Ahmed and Francesca Cassidy, pivoting to C-suite communities and events to navigate AI and digital risk.

Olympus is doubling down on innovation in respiratory care with strategic leadership appointments and advancements in robotic bronchoscopy, AI, and single-use scopes. A deeper look at the company's evolving strategy.

Political instability & funding cuts are driving US life science talent & investment to Switzerland. Basel is poised to become a global innovation hub, but what does this mean for American competitiveness?

A contentious proxy battle at cannabis firm MediPharm Labs concluded with shareholders rejecting a challenge from activist investor Apollo Technology Capital, backing the company's existing management team and strategic direction.

Dr. Stuart S. Martin's groundbreaking work at UMD is revolutionizing cancer diagnostics and treatment, with a focus on early detection of metastasis and a new platform for personalized care.

The Joint Commission has appointed a leading CDC infectious disease expert, signaling a potential shift toward bolstering infection prevention standards and data-driven healthcare quality improvements.

S&P Global’s appointment of former PwC Global Chairman Robert Moritz aims to bolster risk management and governance as the company navigates a complex economic landscape and expands its ‘Essential Intelligence’ offerings.

B. Riley Securities' addition of healthcare investment banking leader Greg Crooks signals a strategic move as the sector navigates patent cliffs, AI disruption, and a return to strategic M&A.

Ball Corporation taps supply chain veteran Ronald J. Lewis as its new CEO, signaling a strategic focus on operational efficiency and sustainability amid shifting market demands and a robust packaging industry.

Australian biotech Vaxxas is poised to revolutionize vaccine delivery with its innovative HD-MAP technology. A new manufacturing facility and positive clinical trial data signal a potential shift in global health access.